STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

RxSight (NASDAQ: RXST), an ophthalmic medical device company focused on post-cataract surgery customized vision solutions, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference.

The company's management will engage in a fireside chat scheduled for April 8, 2025, at 9:45 AM PT / 12:45 PM ET. Interested parties can access both the live presentation and archived recording through RxSight's investor relations website at https://investors.rxsight.com/.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.34% News Effect

On the day this news was published, RXST declined 1.34%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 24th Annual Needham Virtual Healthcare Conference.

RxSight’s management is scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 9:45 a.m. Pacific Time / 12:45 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com


FAQ

When is RxSight (RXST) presenting at the Needham Healthcare Conference 2025?

RxSight (RXST) will present on April 8, 2025, at 9:45 AM Pacific Time / 12:45 PM Eastern Time.

How can investors watch RxSight's (RXST) Needham Conference presentation?

Investors can watch the live and archived webcast through RxSight's investor relations website at https://investors.rxsight.com/.

What type of medical devices does RxSight (RXST) specialize in?

RxSight specializes in ophthalmic medical devices that provide high-quality customized vision to patients after cataract surgery.

Which healthcare conference is RxSight (RXST) participating in?

RxSight is participating in the 24th Annual Needham Virtual Healthcare Conference.
Rxsight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Latest SEC Filings

RXST Stock Data

516.42M
38.59M
5.56%
96.93%
13.31%
Medical Devices
Ophthalmic Goods
Link
United States
ALISO VIEJO